Tricuspid stenosis echocardiography

Revision as of 22:14, 17 September 2014 by Rim Halaby (talk | contribs)
Jump to navigation Jump to search

Tricuspid stenosis Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Tricuspid stenosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Tricuspid stenosis echocardiography On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tricuspid stenosis echocardiography

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tricuspid stenosis echocardiography

CDC on Tricuspid stenosis echocardiography

Tricuspid stenosis echocardiography in the news

Blogs on Tricuspid stenosis echocardiography

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Tricuspid stenosis echocardiography

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Transthoracic echocardiography (TTE) should be performed in a patient with suspected tricuspid stenois to confirm the diagnosis, determine the etiology, and establish the baseline severity.

Echocardiography

TEE performed among patients with suspected TS to confirm the diagnosis and determine the anatomic and hemodynamic characteristics of the tricuspid valve. TEE allows the evaluation of the following:

  • Valve thickening and calcification
  • Chordal thickening and calcification
  • Decreased mobility
  • Immobility of the leaflets (suggestive of carcinoid syndrome)
  • Tumors or metastatic lesions
  • Valvular vegetations (suggestive of infective endocarditis)
  • Right atrial ball valve thrombus

Doppler echocardiography is useful to assess the severity of tricuspid stenosis through the evaluation of the transvalvular gradient. TS is mainly characterized by an increased transvalvular gradient. Using continuous wave doppler across the tricuspid valve in apical-4-chamber view, the peak gradient can be calculated using the modified Bernoulli equation. Pressure half time can be used but is not validated for triscuspid stenosis.

The assessment of the tricuspid valve area is limited by the usual association of TS with tricuspid regurgitation. The coexistence of tricuspid regurgitation causes the underestimation of the valvular ares; nevertheless, a tricuspid valve area < 1.0 cm2 is associated with increased severity. Calculation of tricuspid valve area with the continuity equation:[1]

Tricuspid valve area = ( annulus PW Vti * Cross sectional area of the annulus) / valve CW Vti

Assessment of Tricuspid Stenosis Severity with Echocardiography

TTE findings that are associated with increased severity of tricuspid stenosis include:

  • Mean pressure gradient >5 mm Hg,
  • Pressure half-time >190 milliseconds
  • Tricuspid valve area < 1.0 cm2
  • Enlargement of the right atrium
  • Enlargement of the inferior vena cava

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary[2]

Class I
"1. TTE is indicated in patients with TS to assess the anatomy of the valve complex, evaluate severity of stenosis, and characterize any associated regurgitation and/or left-sided valve disease. (Level of Evidence: C)"

References

  1. Fawzy ME, Mercer EN, Dunn B, al-Amri M, Andaya W (1989). "Doppler echocardiography in the evaluation of tricuspid stenosis". Eur Heart J. 10 (11): 985–90. PMID 2591399.
  2. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA; et al. (2014). "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0000000000000029. PMID 24589852.

Template:WH

Template:WS